A detailed history of Hfr Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Hfr Wealth Management, LLC holds 37,017 shares of AMGN stock, worth $11.9 Million. This represents 2.95% of its overall portfolio holdings.

Number of Shares
37,017
Previous 36,838 0.49%
Holding current value
$11.9 Million
Previous $10.5 Million 10.43%
% of portfolio
2.95%
Previous 1.8%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $47,032 - $57,156
179 Added 0.49%
37,017 $11.6 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $65,873 - $79,517
245 Added 0.67%
36,838 $10.5 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $21,223 - $23,942
83 Added 0.23%
36,593 $10.5 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $127,910 - $158,804
-585 Reduced 1.58%
36,510 $9.81 Million
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $41,568 - $49,153
194 Added 0.53%
37,095 $8.24 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $21,901 - $26,694
97 Added 0.26%
36,901 $8.92 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $61,151 - $77,699
-267 Reduced 0.72%
36,804 $9.67 Million
Q3 2022

Nov 07, 2022

SELL
$224.46 - $253.15 $67,338 - $75,945
-300 Reduced 0.8%
37,071 $8.36 Million
Q2 2022

Aug 11, 2022

BUY
$230.71 - $256.74 $139,810 - $155,584
606 Added 1.65%
37,371 $9.09 Million
Q1 2022

May 10, 2022

BUY
$219.27 - $242.57 $126,080 - $139,477
575 Added 1.59%
36,765 $8.89 Million
Q4 2021

Feb 07, 2022

BUY
$198.88 - $227.6 $202,062 - $231,241
1,016 Added 2.89%
36,190 $8.14 Million
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $316,282 - $370,563
1,490 Added 4.42%
35,174 $7.48 Million
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $7.87 Million - $8.73 Million
33,684 New
33,684 $8.21 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hfr Wealth Management, LLC Portfolio

Follow Hfr Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hfr Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hfr Wealth Management, LLC with notifications on news.